Skip Navigation
Skip to contents

대한신장학회

My KSN 메뉴 열기

간행물 검색
Prediction of the Clinical Outcomes in Patients with CRRT using Body Composition Monitoring: A Machine Learning Approach to a Multicenter Cohort Study
Kyung Don Yoo, Junhyug Noh, Jung Nam An, Hyung Jung Oh, Harin Rhee, Jang-Hee Cho, Dong Ki Kim, Sejoong Kim, Jung Pyo Lee
2021 ; 2021(1):
논문분류 :
춘계학술대회 초록집
Objective: In a multicenter cohort study, a total of 784 patients with severe AKI requiring CRRT were recruited, and body composition monitoring (BCM) using InBody® was performed on patients who started CRRT at nine tertiary hospitals in Korea from 2017 Nov to 2019 Nov. The comparison for sequential changes of total body water was performed between the survivor and non-survivor groups using mixed-effects linear regression analysis. Machine learning algorithms were used for the modeling to predict mortality. Methods: Of the 784 patients (mean age: 63.5 years), 521 (66.4%) were male. The mean APACHE II score was 29.2 ± 10.3 in the non-survivor group and 26.5 ± 9.0 in the survivor group. There were no significant differences in the volume status assessed by body weight and BCM at baseline. After adjusting for confounding factors, the survivor group had a marginal benefit from fluid balance in a mixed-effects linear regression (p=0.074). From a range attribute of the decision tree model for predicted mortality, platelet count was found in the first node in the late mortality group (survival duration > 60 days). Patients with survival duration under 60 days showed increased mortality, according to the SOFA score, serum sodium, bilirubin, and target clearance in a decision tree model (AUC=0.957). In the early CRRT group (CRRT initiation with 24hr after ICU admission), patients with high serum bilirubin and high body temperature presented poor prognosis (AUC=0.602). Results: These machine learning approaches showed that conventional parameters for predicting clinical outcomes were interrelated as notable risk factors for mortality augmented by BCM in CRRT patients. Conclusions: Objective: Fluid balance is a critical predictor of patient outcomes with severe acute kidney injury (AKI) requiring continuous renal replacement therapy (CRRT). However, accurate assessment and application of fluid balance monitoring for predicting clinical outcomes in these patients were inconclusive. Methods: In a multicenter cohort study, a total of 784 patients with severe AKI requiring CRRT were recruited, and body composition monitoring (BCM) using InBody® was performed on patients who started CRRT at nine tertiary hospitals in Korea from 2017 Nov to 2019 Nov. The comparison for sequential changes of total body water was performed between the survivor and non-survivor groups using mixed-effects linear regression analysis. Machine learning algorithms were used for the modeling to predict mortality. Results: Of the 784 patients (mean age: 63.5 years), 521 (66.4%) were male. The mean APACHE II score was 29.2 ± 10.3 in the non-survivor group and 26.5 ± 9.0 in the survivor group. There were no significant differences in the volume status assessed by body weight and BCM at baseline. After adjusting for confounding factors, the survivor group had a marginal benefit from fluid balance in a mixed-effects linear regression (p=0.074). From a range attribute of the decision tree model for predicted mortality, platelet count was found in the first node in the late mortality group (survival duration > 60 days). Patients with survival duration under 60 days showed increased mortality, according to the SOFA score, serum sodium, bilirubin, and target clearance in a decision tree model (AUC=0.957). In the early CRRT group (CRRT initiation with 24hr after ICU admission), patients with high serum bilirubin and high body temperature presented poor prognosis (AUC=0.602). Conclusions: These machine learning approaches showed that conventional parameters for predicting clinical outcomes were interrelated as notable risk factors for mortality augmented by BCM in CRRT patients.
위로가기

(06022) 서울시 강남구 압구정로 30길 23 미승빌딩 301호

Copyright© 대한신장학회. All rights reserved.